24 Sep 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Oramed Pharmaceuticals, a developer of oral drug delivery systems, has received patent from Russia's Federal Service for Intellectual Property, Patents and Trademarks (ROSPATENT) for the company's invention, titled 'Methods and compositions for oral administrations of proteins'.
The patent covers a core concept of the company's technology for the oral delivery of drugs currently delivered via injection. Oral delivery can greatly improve patient compliance and outcomes.
This patent has also been granted in New Zealand, South Africa and China. Oramed's intellectual property portfolio now consists of nine issued patents and 26 patents pending.